1. Home
  2. ESPR vs HIPO Comparison

ESPR vs HIPO Comparison

Compare ESPR & HIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • HIPO
  • Stock Information
  • Founded
  • ESPR 2008
  • HIPO 2015
  • Country
  • ESPR United States
  • HIPO United States
  • Employees
  • ESPR N/A
  • HIPO N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • HIPO Property-Casualty Insurers
  • Sector
  • ESPR Health Care
  • HIPO Finance
  • Exchange
  • ESPR Nasdaq
  • HIPO Nasdaq
  • Market Cap
  • ESPR 410.2M
  • HIPO 440.1M
  • IPO Year
  • ESPR 2013
  • HIPO N/A
  • Fundamental
  • Price
  • ESPR $1.89
  • HIPO $30.43
  • Analyst Decision
  • ESPR Buy
  • HIPO Buy
  • Analyst Count
  • ESPR 6
  • HIPO 3
  • Target Price
  • ESPR $7.25
  • HIPO $28.00
  • AVG Volume (30 Days)
  • ESPR 5.1M
  • HIPO 139.9K
  • Earning Date
  • ESPR 02-25-2025
  • HIPO 03-05-2025
  • Dividend Yield
  • ESPR N/A
  • HIPO N/A
  • EPS Growth
  • ESPR N/A
  • HIPO N/A
  • EPS
  • ESPR N/A
  • HIPO N/A
  • Revenue
  • ESPR $295,451,000.00
  • HIPO $334,700,000.00
  • Revenue This Year
  • ESPR $186.04
  • HIPO N/A
  • Revenue Next Year
  • ESPR $11.25
  • HIPO $22.26
  • P/E Ratio
  • ESPR N/A
  • HIPO N/A
  • Revenue Growth
  • ESPR 187.12
  • HIPO 84.92
  • 52 Week Low
  • ESPR $1.58
  • HIPO $8.78
  • 52 Week High
  • ESPR $3.94
  • HIPO $34.24
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 39.38
  • HIPO 64.76
  • Support Level
  • ESPR $1.71
  • HIPO $25.81
  • Resistance Level
  • ESPR $2.26
  • HIPO $28.59
  • Average True Range (ATR)
  • ESPR 0.14
  • HIPO 1.15
  • MACD
  • ESPR -0.01
  • HIPO 0.42
  • Stochastic Oscillator
  • ESPR 33.33
  • HIPO 87.44

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About HIPO Hippo Holdings Inc.

Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the Company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.

Share on Social Networks: